A model can be proposed whereby ZNF217 cooperates with Aurora-A, BCL2L1 or eEF1A2 in neoplastic progression of breast cancer through genomic co-amplification and/or through ZNF217-driven molecular regulation, which might amplify the impact of any genomic amplification. The gene discussed is BCL2L1; the disease is breast cancer.